← Open Payments lookup

WILLIAM WARNES: Open Payments

NPI 1710937636 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,040 in 54 payments from 12 companies in 2025. Trend: 2023 $558 · 2024 $181 · 2025 $1,040

Food & beverage: $1,040
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.6$224
Otsuka America Pharmaceutical, Inc.9$156
ABBVIE INC.13$137
Neurocrine BioSciences, Inc.6$134
Alkermes, Inc.7$126
Janssen Pharmaceuticals, Inc3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$51
Neuronetics, Inc.1$48
Teva Pharmaceuticals USA, Inc.2$31
Axsome Therapeutics, Inc.2$31

Products named: COBENFY, VRAYLAR, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, REXULTI, CAPLYTA, NEUROSTAR TMS THERAPY SYSTEM.

Industry payments across KS — which companies pay providers there.